Price
No data yet.
Social Signal Score
Analyst Ratings
8 analystsRevenue
$34.17M-74.19%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Paul Josephs
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 382
- Beta
- 1.08
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -0.14
Financials
Revenue
$34.17M-74.2%Net Income
$-6.16M-285.9%EBITDA
$4.13M-48.5%Free Cash Flow
$-2.70M-162.3%EPS (diluted)
$-0.19-258.3%Shares Outstanding (diluted)
37.57M+36.5%Operating Expenses
$9.51MCash & Debt
$17.24MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $129.46M | $-30.79M | $-0.92 |
| 2025 | $128.87M | $-38.72M | $-1.27 |
| 2024 | $128.26M | $12.01M | $0.39 |
| 2023 | $103.27M | $-99.56M | $-3.32 |
| 2022 | $111.27M | $-116.72M | $-3.97 |
| 2021 | $100.87M | $-32.29M | $-1.12 |
| 2020 | $160.07M | $-38.19M | $-1.31 |
| 2019 | $557.56M | $2.12M | $0.07 |
| 2018 | $524.23M | $24.83M | $0.90 |
| 2017 | $532.26M | $10.59M | $0.39 |
| 2016 | $541.10M | $-11.64M | $-0.43 |
| 2015 | $539.26M | $13.54M | $0.50 |
| 2014 | $476.81M | $19.14M | $0.71 |
| 2013 | $441.71M | $22.59M | $0.87 |
Valuation
LFCRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (3)
- Newsglobenewswire.com·5d ago·Neutral
Halper Sadeh LLC is Investigating Whether LFCR and SSTI are Obtaining Fair Deals for their Shareholders Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
View source ↗ - Newsnewsfilecorp.com·6d ago·Neutral
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Lifecore Biomedical, Inc. (LFCR) Bala Cynwyd, Pennsylvania--(Newsfile Corp. - September 29, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Lifecore Biomedical, Inc. ("Lifecore Biomedical" or the "Company") (NASDAQ: LFCR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Webs…
View source ↗ - Newsbusinesswire.com·7d ago·Neutral
LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lifecore Biomedical, Inc. (NASDAQ: LFCR) to Webster Equity Partners for $6.28 per share in cash plus one non-tradable contingent value right per share. Halper Sadeh encourages Lifecore shareholders to click here to learn more about their rights and options or cont…
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $-0.30 per share
Typical surprise -5.6% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$-0.19 vs $-0.19beat
- Wed, May 6$-0.43 vs $-0.24miss
- Mon, Mar 9$-0.19 vs $-0.18miss
- Thu, Nov 6$-0.29 vs $-0.30beat
- Thu, Aug 7$-0.10 vs $-0.09miss
- Thu, Apr 3$-0.47 vs $-0.14miss
Estimates and results for LFCR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by LFCR officers and directors.
- Bought
- $7.3m
- Sold
- $9.9m
5 trades
10 trades
- English Aron R.sold
- English Aron R.sold
- English Aron R.sold
- English Aron R.sold
- English Aron R.sold
- English Aron R.sold
- English Aron R.sold
- English Aron R.sold
85 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in LFCR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.